Media Newsroom of

Scailyte AG

Follow on Social Network
Scailyte AG

Scailyte develops and applies AI technology for the interpretation of single-cell data. We aim to unlock human's single-cell 'hidden secrets' and convert highly complex data into new medical insights and usable knowledge.

Scailyte Raises CHF 2.75M in Seed Funding and Gains Swisscom Ventures & Zürcher Kantonalbank as Investors

Scailyte Raises CHF 2.75M in Seed Funding and Gains Swisscom Ventures & Zürcher Kantonalbank as Investors

Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 2.75M in seed funding and gained Swisscom Ventures as a strategic investor. Zürcher Kantonalbank also joined the financing round, alongside the existing shareholders,…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login